February 23, 2018 / 12:04 PM / in 6 months

BRIEF-Mallinckrodt Receives FDA Acceptance Of Stannsoporfin New Drug Application Filing

Feb 23 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT RECEIVES FDA ACCEPTANCE OF STANNSOPORFIN NEW DRUG APPLICATION FILING

* MALLINCKRODT PLC - UNDER PRESCRIPTION DRUG USER FEE ACT, FDA HAS SET ITS ACTION DATE TO RESPOND TO STANNSOPORFIN NDA AS AUGUST 22, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below